Imperial Valley News Center
Washington, DC - Assistant Secretary of State for Consular Affairs Carl Risch will travel to Mexico November 14-17, to review consular operations at the U.S. Embassy in Mexico City as well as at the U.S. Consulate General in Monterrey.
Washington, DC - From November 13-17, the U.S. Department of State and the U.S. Department of Education will celebrate International Education Week (IEW) by encouraging Americans and international students to seek opportunities to study abroad, make connections with peers in other countries, and ultimately see themselves as actors in and shapers of both their local communities and an interconnected world.
Admiral Michael S. Rogers and Assistant Secretary for Diplomatic Security Michael T. Evanoff To Speak at the Overseas Security Advisory Council's 32nd Annual Briefing
Washington, DC - More than 1,500 public and private security professionals from U.S. businesses, academia, faith-based institutions, nongovernmental organizations, and the federal government will gather at the Hyatt Regency Crystal City on November 15-16, 2017, for the Overseas Security Advisory Council (OSAC) 32nd Annual Briefing.
Sacramento, California - What California industry directly employs more than 104,000 people with a ripple effect that supports an additional 285,000 full-time jobs in retail, construction and other sectors?
Washington, DC - Secretary of State Rex W. Tillerson: "On behalf of the people of the United States of America, I send best wishes to the people of Angola as you celebrate your 42nd year of independence on November 11.
Washington, DC - As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes. Selling these unapproved products with unsubstantiated therapeutic claims is not only a violation of the Federal Food, Drug and Cosmetic Act, but also can put patients at risk as these products have not been proven to be safe or effective. The deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.
Page 11 of 2122